Skip to content
AwardedUnited KingdomGoods£100,000

Support of existing Low Density Lipid (LDL) Removal Apheresis Systems

Published
Published 18 February 2026
Deadline
Closed 31 August 2025

Overview

NHS Blood and Transplant (NHBST) is a Special Health Authority within the NHS and is responsible for the provision of blood components and a range of associated laboratory and patient therapeutic services to hospitals in England and Wales. Therapeutic Apheresis Services (TAS) provide lifesaving and life-enhancing therapies to adults and children from across a range of clinical specialties. Patients receive treatment either at their hospital bedside or where clinically appropriate as an outpatient in an NHS Blood and Transplant (NHSBT) unit. NHSBT provides regional access to apheresis services from 11 dedicated units across England and Wales. Requirement for support of existing Low Density Lipid (LDL) Removal Apheresis Systems.

Key details

Country
United Kingdom
Status
Awarded
Category
Goods
Estimated value
£100,000
Procedure
Selective
SME suitable
No
Published
18 February 2026
Deadline
Closed
Classification (CPV)
Repair and maintenance services of medical and surgical equipment

Award outcome

Awarded value
£337,798
Award date
20 January 2026
Contract period
20 January 2026 → 19 January 2028
Winner
  • Fresenius Medical Care (UK) Limited

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    18 February 2026

Contracting authority

  • NHS Blood and Transplant

    Buyer

    Bristol, United Kingdom

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Support of existing Low Density Lipid (LDL) Removal Apheresis Systems — won by Fresenius Medical Care (UK) Limited — Skim